Shravan Leonard-Murali1, Hassan Nasser2, Tommy Ivanics1, Dania Shakaroun3, Jeffrey Genaw1. 1. Department of Surgery, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA. 2. Department of Surgery, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA. hnasser2@hfhs.org. 3. Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA.
Abstract
BACKGROUND: The safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) to treat obesity and associated comorbidities, including diabetes mellitus, is well established. As diabetes may add risk to the perioperative period, we sought to characterize perioperative outcomes of these surgical procedures in diabetic patients. METHODS: Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database, we identified patients who underwent LSG and LRYGB between 2015 and 2017, grouping by non-diabetics (NDM), non-insulin-dependent diabetics (NIDDM), and insulin-dependent diabetics (IDDM). Primary outcomes included serious adverse events, 30-day readmission, 30-day reoperation, and 30-day mortality. Univariate and multivariable analyses were used to evaluate the outcome in each diabetic cohort. RESULTS: Multivariable analysis of patients who underwent LSG (with NDM patients as reference) showed higher 30-day mortality (NIDDM AOR = 1.52, p = 0.043; IDDM AOR = 1.91, p = 0.007) and risk of serious adverse events (NIDDM AOR = 1.15, p < 0.001; IDDM AOR = 1.58, p < 0.001) in the diabetic versus NDM groups. Multivariable analysis of patients who underwent LRYGB (with NDM patients as reference) showed higher risk of serious adverse events (NIDDM AOR = 1.09, p = 0.014; IDDM AOR = 1.43, p < 0.001) in the diabetic versus NDM groups. CONCLUSIONS: Diabetics who underwent LSG and LRYGB had higher rates of several perioperative complications compared with non-diabetics. IDDM had a stronger association with several perioperative complications compared with NIDDM. This increase in morbidity and mortality is modest and should be weighed against the real benefits of bariatric surgery in patient with obesity and diabetes mellitus.
BACKGROUND: The safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) to treat obesity and associated comorbidities, including diabetes mellitus, is well established. As diabetes may add risk to the perioperative period, we sought to characterize perioperative outcomes of these surgical procedures in diabeticpatients. METHODS: Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database, we identified patients who underwent LSG and LRYGB between 2015 and 2017, grouping by non-diabetics (NDM), non-insulin-dependent diabetics (NIDDM), and insulin-dependent diabetics (IDDM). Primary outcomes included serious adverse events, 30-day readmission, 30-day reoperation, and 30-day mortality. Univariate and multivariable analyses were used to evaluate the outcome in each diabetic cohort. RESULTS: Multivariable analysis of patients who underwent LSG (with NDM patients as reference) showed higher 30-day mortality (NIDDM AOR = 1.52, p = 0.043; IDDM AOR = 1.91, p = 0.007) and risk of serious adverse events (NIDDM AOR = 1.15, p < 0.001; IDDM AOR = 1.58, p < 0.001) in the diabetic versus NDM groups. Multivariable analysis of patients who underwent LRYGB (with NDM patients as reference) showed higher risk of serious adverse events (NIDDM AOR = 1.09, p = 0.014; IDDM AOR = 1.43, p < 0.001) in the diabetic versus NDM groups. CONCLUSIONS:Diabetics who underwent LSG and LRYGB had higher rates of several perioperative complications compared with non-diabetics. IDDM had a stronger association with several perioperative complications compared with NIDDM. This increase in morbidity and mortality is modest and should be weighed against the real benefits of bariatric surgery in patient with obesity and diabetes mellitus.
Authors: Pedro Souteiro; Sandra Belo; João Sérgio Neves; Daniela Magalhães; Rita Bettencourt Silva; Sofia Castro Oliveira; Maria Manuel Costa; Ana Saavedra; Joana Oliveira; Filipe Cunha; Eva Lau; César Esteves; Paula Freitas; Ana Varela; Joana Queirós; Davide Carvalho Journal: Obes Surg Date: 2017-02 Impact factor: 4.129
Authors: Scott Kizy; Cyrus Jahansouz; Michael C Downey; Nathanael Hevelone; Sayeed Ikramuddin; Daniel Leslie Journal: Obes Surg Date: 2017-11 Impact factor: 4.129
Authors: Jan Peter Yska; Eric N van Roon; Anthonius de Boer; Hubert G M Leufkens; Bob Wilffert; Loek J M de Heide; Frank de Vries; Arief Lalmohamed Journal: JAMA Surg Date: 2015-12 Impact factor: 14.766
Authors: Tom Wiggins; Dimitri J Pournaras; Elena Priestman; Alan Osborne; Daniel R Titcomb; Ian Finlay; James Hopkins; Marianne Hollyman; Matthew Mason; Hamish Noble; David Mahon; Richard Welbourn Journal: Obes Surg Date: 2021-03-25 Impact factor: 4.129
Authors: Elisa Morales-Marroquin; Luyu Xie; Luigi Meneghini; Nestor de la Cruz-Muñoz; Jaime P Almandoz; Sunil M Mathew; Benjamin E Schneider; Sarah E Messiah Journal: Obesity (Silver Spring) Date: 2020-11-20 Impact factor: 9.298